Extract

The purpose of this study is to: - Test the safety of the research study drug, lenalidomide, when given with Idarubicin and Cytarabine - See how many respond to combination treatment with lenalidomide, Idarubicin and Cytarabine - See how long people respond to this combination therapy - See how long people live after being treated with this combination of drugs

Inclusion criteria

• myelodysplastic syndrome,Acute Myeloid Leukemia

Links

• ictrp
• nct